Grasp the law, face up to the crisis, concentrate and forge ahead. The company will deploy the production and operation work in the second half of the year.
Release time:
2022-07-24
News from our newspaper # February 15 and 16 , the company held a business analysis meeting in the first half of 2022 to analyze and exchange the work of all subordinate enterprises in the first half of the year and deploy the work of the company in the second half of the year.
Compared with the situation in which senior and middle-level managers gathered together to report and communicate in the previous half year, the format of this meeting has been adjusted, I .e. according to the different business scope, the directly affiliated enterprises, the pharmaceutical sector and the cement sector will each arrange half a day. In addition to the "Convention" business management teams reporting on the work in the first half of the year, the cement sector has increased the benchmarking analysis content of major process and technical indicators, the leaders in charge of production, sales and research and development in the pharmaceutical sector will also make separate reports and analysis on their respective work. The leaders of the group analyzed and commented on the gains and losses of each enterprise in the first half of the year, and put forward suggestions for improvement according to the different situations of each enterprise. In the last half of the day, we will arrange and put forward requirements for the overall work of the company in the second half of the year.
At the overall work meeting, Xiang Chongping, deputy general manager of the group company, made an overall analysis of the company's human resources work in the first half of the year from four aspects: personnel status, labor cost, talent cultivation, and labor and employment compliance management. Chen Tianci, chairman of the board of supervisors, started from three aspects: the occurrence of safety accidents, the development of safety and environmental protection supervision and management, and the problems in safety management, summarize and analyze the safety and environmental protection management in the first half of the year, analyze the bidding and negotiation of subordinate enterprises, and point out the problems that should be paid attention to in the bidding process. Lan Xiaolong, head of finance, made financial analysis on the group's financial situation and profitability in the first half of the year. Zhu Jianwei, secretary of the board of directors, analyzed and expounded the problems that should be paid attention to in the future work from the perspective of the management and development of listed companies. Yu Jianhong, general manager of
Group Company, summarized the overall operation of the company in the first half of the year and arranged the main work in the second half of the year under the title of "Grasping the Law, Facing up to the Crisis, Concentrating and Moving Forward. After comparing and analyzing the completion of major economic indicators in the same period in recent years, he pointed out the highlights of the work of various enterprises in the first half of the year in the implementation of investment and technological transformation projects, the improvement of the competitiveness of some production lines (products), the improvement of internal management level, and the prevention and control of the new coronary pneumonia epidemic. He stressed that the market downturn has brought about a sharp decline in profits, slow endogenous growth and extension development, and defects in investment decisions and project construction management, and make an analysis and prediction of the industry situation of each business segment.
According to the actual situation of the company's enterprises, Yu Jianhong made arrangements for the key work in the second half of the year. The main contents include: from establishing crisis awareness, improving the ability to identify, use and overcome crises, changing development concepts and business concepts, strengthening team cooperation spirit, strengthening the authorization and responsibility of the management team, etc., to improve the combat effectiveness of the management team; speed up the promotion of investment, technological transformation and product development projects, and increase new profit points; Continue to do a good job in fine management, benchmarking management, PDCA cycle management and internal control management, adhere to the "innovation, promotion; Cost reduction and efficiency enhancement" target requirements, continue to improve core competitiveness; Grasp market trends and improve marketing capabilities; Strengthen risk management and control of project investment; continue to further promote the construction of "digital intelligence factory", continue to strengthen safety, environmental management, etc.
Yu Jianhong stressed that the turbulence and change of the environment and the market are inevitable, but the market law and essence will not change. The pursuit of low cost, high quality and high performance will not change to better meet the needs of users' life and production. He hopes that all cadres and employees of the peak will unite their efforts, forge ahead, persevere in relying on innovation and reform, improve the core competitiveness of the enterprise, and ensure the sustainable and healthy development of the company. Jiang Xiaomeng, chairman of
group company, pointed out in the concluding speech of the meeting that the competition of enterprises is ultimately the competition of talents and the competition of enterprise management teams. In order to further develop with high quality, it is necessary to build an excellent management team with full competitiveness and adapt to the all-weather competitive environment. He requires every manager of the peak to have a strong sense of professionalism and a high sense of responsibility, courage and prudence, and extraordinary wisdom to be competent for the work ability of leadership positions; has serious discipline, The quality of strict governance of the enterprise, fairness and decency, the moral character of clear rewards and punishments, the tolerance of brainstorming, trust in subordinates, and the style of caring for employees and close contact with employees; have the attitude of seeking truth from facts and the quality of being honest and honest, set an example by example, set an example and be strict in self-discipline style and spirit; have the ability to pay attention to learning, keep pace with the times, and constantly improve their own quality to adapt to change. Only in this way can enterprises be in an invincible position in the market competition.
Jiang Xiaomeng requires all enterprise managers to improve not only their ability to find problems, but also their ability to solve problems in their future work. Daily production and operation should be standardized management, system improvement, strict but not dead, alive but not chaotic; Increase the application of intelligent and information scenes to improve labor productivity; Strengthen lean production to ensure that enterprises operate in a standardized, scientific and efficient range; continuously carry out "Three Decreases and Three Improvements" to enhance the competitiveness of enterprises and products; know awe, keep precepts, and keep the bottom line in management. He hoped that the management teams of all enterprises would rationally look at the current market environment, actively seek breakthrough directions, constantly make up for their own shortcomings, implement the arrangements of the meeting in a down-to-earth manner, and go all out to do a good job in the second half of the year. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31